These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5299836)

  • 41. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 42. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.
    BERTLER A; FALCK B; ROSENGREN E
    Acta Pharmacol Toxicol (Copenh); 1963; 20():317-21. PubMed ID: 14162814
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 44. Depressed states and indolealkylamines.
    Coppen AJ
    Adv Pharmacol (1962); 1968; 6(Pt B):283-91. PubMed ID: 5301640
    [No Abstract]   [Full Text] [Related]  

  • 45. The metabolism of 5-hydroxytryptamine in the methionine sulfoximine epileptogenic rat brain.
    Sellinger OZ; Dietz DD
    J Pharmacol Exp Ther; 1981 Jan; 216(1):77-82. PubMed ID: 6161244
    [No Abstract]   [Full Text] [Related]  

  • 46. Autoradiographic studies on distribution of L-3,4-dihydroxyphenylalanine (L-DOPA)-14C and L-5-hydroxytryptophan (L-5-HTP)-14C in the cat brain.
    Miyakoshi N; Tanaka M; Shindo H
    Jpn J Pharmacol; 1980 Dec; 30(6):795-805. PubMed ID: 6972460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of narcotics on the uptake of serotonin precursors by the rat brain.
    Larson AA; Takemori AE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):216-23. PubMed ID: 299890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.
    Neels OC; Koopmans KP; Jager PL; Vercauteren L; van Waarde A; Doorduin J; Timmer-Bosscha H; Brouwers AH; de Vries EG; Dierckx RA; Kema IP; Elsinga PH
    Cancer Res; 2008 Sep; 68(17):7183-90. PubMed ID: 18757434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of antidepressants on thyroid stimulating hormone release in rats under ether stress.
    Kadono Y; Kaneda H; Maeda K
    Psychiatry Clin Neurosci; 1995 Aug; 49(4):231-6. PubMed ID: 9179943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dietary lipid upon some enzymes of significance in biogenic amine metabolism in the rat.
    Century B; Horwitt MK
    J Nutr; 1968 Aug; 95(4):509-16. PubMed ID: 5302072
    [No Abstract]   [Full Text] [Related]  

  • 52. Uptake and utilization of [beta-11C]5-hydroxytryptophan in human brain studied by positron emission tomography.
    Reibring L; Agren H; Hartvig P; Tedroff J; Lundqvist H; Bjurling P; Kihlberg T; Långström B
    Psychiatry Res; 1992 Dec; 45(4):215-25. PubMed ID: 1292039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex differences in serotonin synthesis from 5-hydroxytryptophan in neonatal rat brain.
    Hardin CM
    Brain Res; 1973 Sep; 59():437-9. PubMed ID: 4542918
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of the administration of L-5-hydroxytryptophan and a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    J Neurochem; 1978 Sep; 31(3):613-20. PubMed ID: 308095
    [No Abstract]   [Full Text] [Related]  

  • 55. PET with hydroxytryptophan as tracer in hormone-refractory prostatic adenocarcinoma: evaluation of decarboxylation in vivo.
    Kälkner KM; Nilsson S; Bergström M; Lindner KJ; Westerberg G; Långström B; Westlin JE
    In Vivo; 1997; 11(5):377-81. PubMed ID: 9427038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of 5-hydroxytryptophan in the isolated perfused rat lung.
    Ben-Harari RR; Parent Ermini A; Kleinerman J
    Pharmacology; 1990; 41(5):272-9. PubMed ID: 1709288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Centrally-mediated cardiovascular effects of 5-hydroxytryptophan in MAO-inhibited dogs: modification by autonomic antagonists.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):200-10. PubMed ID: 1080042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Uptake of 5-hydroxytryptamine and 5-hydroxytrytophan in normally catecholamine-containing neurons of the central nervous system].
    Lichtensteiger W; Mutzner U; Langemann H
    Helv Physiol Pharmacol Acta; 1966 Nov; 68():C101-2. PubMed ID: 5299627
    [No Abstract]   [Full Text] [Related]  

  • 59. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines.
    Lichtensteiger W; Mutzner U; Langemann H
    J Neurochem; 1967 May; 14(5):489-97. PubMed ID: 5297947
    [No Abstract]   [Full Text] [Related]  

  • 60. Monoamine precursors in the treatment of depression.
    Carroll BJ
    Clin Pharmacol Ther; 1971; 12(5):743-61. PubMed ID: 4936139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.